Cargando…

Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry

PURPOSE: As a means of limiting normal tissue toxicity, proton-beam therapy (PBT) is an emerging radiation modality for glioblastoma (GBM) reirradiation. However, data for recurrent GBM treated with PBT reirradiation is limited. Therefore, we analyzed treatment patterns, toxicities, and clinical out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeed, Ali M., Khairnar, Rahul, Sharma, Ankur M., Larson, Gary L., Tsai, Henry K., Wang, Chiachien J., Halasz, Lia M., Chinnaiyan, Prakash, Vargas, Carlos E., Mishra, Mark V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557126/ https://www.ncbi.nlm.nih.gov/pubmed/33083661 http://dx.doi.org/10.1016/j.adro.2020.03.022

Ejemplares similares

Proton Reirradiation for Locoregionally Recurrent Breast Cancer
por: LaRiviere, Michael J., et al.
Publicado: (2021)

Clinical Outcomes of Intensity Modulated Proton Therapy Reirradiation for Gynecologic Malignancies
por: Pollock, Ariel E., et al.
Publicado: (2023)

Reirradiation for Rectal Cancer Using Pencil Beam Scanning Proton Therapy: A Single Institutional Experience
por: Koroulakis, Antony, et al.
Publicado: (2020)

Reirradiation for recurrent craniopharyngioma
por: Foran, Sarah J., et al.
Publicado: (2020)

Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies
por: Moningi, Shalini, et al.
Publicado: (2019)

Reirradiation for Locoregional Recurrent Breast Cancer
por: Fattahi, Sayeh, et al.
Publicado: (2020)

Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial
por: Parzen, Jacob S., et al.
Publicado: (2021)

Hyperfractionated-Accelerated Reirradiation with Proton Therapy for Radiation-Associated Breast Angiosarcoma
por: Looi, Wen Shen, et al.
Publicado: (2022)

Risk of carotid blowout after reirradiation with particle therapy
por: Dale, Jon Espen, et al.
Publicado: (2017)

Magnetic Resonance–Guided Reirradiation for Local Recurrence Within the Prostate or in the Prostate Bed: Preliminary Results of a Prospective Registry Study
por: Michalet, Morgan, et al.
Publicado: (2021)

Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry
por: Eckstein, Jacob, et al.
Publicado: (2023)

Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry
por: Jongen, Aurélien, et al.
Publicado: (2021)

Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma
por: Lee, Anna, et al.
Publicado: (2023)

Comparison of carbon ion and photon reirradiation for recurrent glioblastoma
por: Lautenschlaeger, F. S., et al.
Publicado: (2021)

Current status and recent advances in reirradiation of glioblastoma
por: Minniti, Giuseppe, et al.
Publicado: (2021)

Stereotactic Body Radiation Therapy Reirradiation for Locally Recurrent Rectal Cancer: Outcomes and Toxicity
por: Smith, Thomas, et al.
Publicado: (2020)

Magnetic resonance imaging guided reirradiation of recurrent and second primary head and neck cancer
por: Chen, Allen M., et al.
Publicado: (2017)

Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy
por: Burr, Adam R., et al.
Publicado: (2020)

An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer
por: Rulach, Robert, et al.
Publicado: (2021)

Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients
por: Wick, Wolfgang, et al.
Publicado: (2019)

Reirradiation of recurrent breast cancer with proton beam therapy: A case report and literature review
por: Lin, Yi-Lan
Publicado: (2019)

Estimating prognosis at the time of repeat whole brain radiation therapy for multiple brain metastases: The reirradiation score
por: Logie, Natalie, et al.
Publicado: (2017)

Patient Prioritization for Proton Beam Therapy in a Cost-neutral Payer Environment: Use of the Clinical Benefit Score for Resource Allocation
por: Sharma, Ankur M, et al.
Publicado: (2019)

Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registry
por: Han, James E., et al.
Publicado: (2020)

Reirradiation of High-Grade Gliomas: A Retrospective Analysis of 198 Patients Based on the Charité Data Set
por: Kaul, David, et al.
Publicado: (2020)

Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma
por: Koong, Amanda J., et al.
Publicado: (2017)

Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration
por: Baron, Jonathan A., et al.
Publicado: (2022)

Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09
por: Mishra, Mark V., et al.
Publicado: (2020)

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy
por: Youssef, Fady F., et al.
Publicado: (2016)

Dose-Escalated Magnetic Resonance Image–Guided Abdominopelvic Reirradiation With Continuous Intrafraction Visualization, Soft Tissue Tracking, and Automatic Beam Gating
por: Chuong, Michael D., et al.
Publicado: (2021)

Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09
por: Mishra, Mark V., et al.
Publicado: (2019)

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group
por: Parzen, Jacob S., et al.
Publicado: (2020)

Multiple Computed Tomography Robust Optimization to Account for Random Anatomic Density Variations During Intensity Modulated Proton Therapy
por: Zhu, Mingyao, et al.
Publicado: (2019)

High-Grade Glioma Radiation Therapy and Reirradiation Treatment Planning Using Translocator Protein Positron Emission Tomography With (18)F-GE-180
por: Fleischmann, Daniel Felix, et al.
Publicado: (2023)

Analysis of patient outcomes following proton radiation therapy for retinoblastoma
por: Mouw, Kent W., et al.
Publicado: (2016)

Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the Anus()()
por: Mohiuddin, Jahan J., et al.
Publicado: (2021)

Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience
por: Prayongrat, Anussara, et al.
Publicado: (2017)

A Novel Salvage Option for Local Failure in Prostate Cancer, Reirradiation Using External Beam or Stereotactic Radiation Therapy: Systematic Review and Meta-Analysis
por: Corkum, Mark T., et al.
Publicado: (2020)

Proton Therapy Outcomes for Head and Neck Cutaneous Melanoma: Proton Collaborative Group Analysis
por: Han, James E., et al.
Publicado: (2022)

Structural basis for polyspecificity in the POT family of proton-coupled oligopeptide transporters
por: Lyons, Joseph A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c7kkqv391memmmstb7h4cu9tj4